This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New York Times: An Investment Fit to Sell

By Ironwood Investment Management

Ironwood SMID Cap Value Strategy portfolio is off to a disappointing start in 2014. For the month of January the strategy declined 4.1%. The strategy's energy, financial services and producer durables stocks underperformed on a relative basis. This weakness was partially offset by relative outperformance in our healthcare, materials and technology stocks.

We bought a position in Platform Specialty Products (PAH) in January. Platform Specialty is the new name for the formerly known MacDermid, specialty chemical company that went private in 2007.

Martin Franklin, chairman of Jarden (JAH), bought MacDermid in October 2013 and renamed it Platform Specialty. The CEO and CFO of MacDermid took no cash in the deal, instead stayed on in their positions and rolled their equity into the new entity.

Platform Specialty starts off with the #1 or #2 position in its markets including metals and plastic finishing, electronics, oil production and drilling, and graphic arts. We believe Franklin's proven deal making ability will allow Platform Specialty to transform itself over the next 3 years into an industry leader, achieve higher earnings and cash flow, and a higher valuation. We purchased the stock in January.

We sold our position in the New York Times Company (NYT), which we had owned since our January 1, 2013 inception date. We believed that the new CEO, appointed in August 2012, would successfully transition the company to the digital age while retaining print revenues, by cutting costs and divesting non-core assets.

Over the next twelve months, management executed their transition strategy relatively quickly, including by selling the Boston Globe and launching an attractive video business. As a result the stock approached our 2016 price target and we sold in January.

We purchased Mallinckrodt PLC (MNK) in June 2013, when it was spun off from Covidien (COV). Mallinckrodt was a collection of somewhat related businesses with a sizeable opportunity to improve revenue growth and margins on existing product lines.

The new management's broader strategy was to transition the company to a more cohesive, faster-growth and higher-margin business. Management quickly executed on their transition to a fully-independent company and the stock approached our 2015 price target. We sold the stock in January.

ADT Corporation (ADT) was spun out as a public company from Tyco in 2012. ADT has a strong franchise, underutilized balance sheet, and was trading at a substantial discount to our target valuation.

Subsequent to our purchase Corvex, an activist firm, got involved. They wanted the company to boost stock repurchases by borrowing off a significantly underleveraged balance sheet. Unfortunately management fell short on execution on several fronts.

They did a poor job of handling the transition to a public company. They failed to fully realize the value from the strong ADT franchise, as management was not prepared for new competition that adversely affected costs and revenues. And they did a poor job in their dealings with Corvex. As a result we believed the transition had become impaired and we sold.

DISCLAIMER: The investments discussed are held in client accounts as of February 28, 2013. These investments may or may not be currently held in client accounts. The reader should not assume that any investments identified were or will be profitable or that any investment recommendations or investment decisions we make in the future will be profitable. Past performance is no guarantee of future results.

Ironwood Investment Management

Ironwood Investment Management

Ironwood Investment Management is an employee-owned investment management firm based in Boston that formed in 1997. It invests in undervalued

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.20 -0.04%
FB $117.41 -0.34%
GOOG $704.16 0.39%
TSLA $209.98 -0.73%
YHOO $37.08 0.38%


Chart of I:DJI
DOW 17,645.89 -14.82 -0.08%
S&P 500 2,043.36 -7.27 -0.35%
NASDAQ 4,701.3810 -15.7130 -0.33%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs